WallStreetZenWallStreetZen

NASDAQ: ZVRA
Zevra Therapeutics Inc Stock Ownership - Who owns Zevra Therapeutics?

Insider buying vs selling

Have Zevra Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Thomas AndersonDirector2023-09-0610,000$4.88
$48.76kBuy
R. Laduane CliftonCFO Secretary Treasurer2023-09-061,000$4.96
$4.96kBuy
John B. BodeDirector2023-09-0510,000$5.13
$51.33kBuy
Joshua SchaferCCO EVP Bus. Development2023-09-05500$5.13
$2.56kBuy
Corey Michael WattonDirector2023-06-23275$5.95
$1.64kBuy
Corey Michael WattonDirector2023-06-09325$5.52
$1.79kBuy
Corey Michael WattonDirector2023-05-30400$5.11
$2.04kBuy
Joshua SchaferCCO EVP Bus. Development2023-05-191,000$5.42
$5.42kBuy
R. Laduane CliftonCFO Secretary Treasurer2023-05-18689$4.95
$3.41kBuy
R. Laduane CliftonCFO Secretary Treasurer2023-05-182,000$4.95
$9.90kBuy

1 of 2

ZVRA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ZVRA insiders and whales buy or sell their stock.

ZVRA Shareholders

What type of owners hold Zevra Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Delaware Street Capital Master Fund LP11.31%4,095,914$24.33MInsider
Samuel J. Braun8.68%3,143,000$18.67MInsider
Christal M. M. Mickle7.43%2,690,545$15.98MInsider
Nantahala Capital Management LLC6.77%2,453,405$14.57MInstitution
Blackrock Inc6.65%2,410,289$14.32MInstitution
Vanguard Group Inc4.54%1,645,140$9.77MInstitution
Travis C. Mickle3.68%1,334,151$7.92MInsider
Geode Capital Management LLC2.01%729,179$4.33MInstitution
Janney Montgomery Scott LLC1.89%683,431$4.06MInstitution
State Street Corp1.76%636,060$3.78MInstitution

1 of 3

ZVRA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ZVRA35.01%33.38%Net Buying
INMB12.71%40.17%Net Selling
CAPR11.25%88.75%Net Buying
MACK23.49%76.51%Net Buying
DRTS2.64%0.00%

Zevra Therapeutics Stock Ownership FAQ

Who owns Zevra Therapeutics?

Zevra Therapeutics (NASDAQ: ZVRA) is owned by 35.01% institutional shareholders, 33.38% Zevra Therapeutics insiders, and 31.62% retail investors. Delaware Street Capital Master Fund LP is the largest individual Zevra Therapeutics shareholder, owning 4.10M shares representing 11.31% of the company. Delaware Street Capital Master Fund LP's Zevra Therapeutics shares are currently valued at $23.76M.

If you're new to stock investing, here's how to buy Zevra Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.